Viveve Medical (NASDAQ: VIVE) reported Q2 EPS of ($0.66), $0.18 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $1.56 million versus the consensus estimate of $1.38 million.

For earnings history and earnings-related data on Viveve Medical (VIVE) click here.